|
1
|
Plaa GL and Priestly BG: Intrahepatic
cholestasis induced by drugs and chemicals. Pharmacol Rev.
28:207–273. 1976.
|
|
2
|
Zimmerman HJ: Drug-induced liver disease.
Drugs. 16:25–45. 1978. View Article : Google Scholar
|
|
3
|
Kossor DC, Meunier PC, Handler JA, Sozio
RS and Goldstein RS: Temporal relationship of changes in
hepatobiliary function and morphology in rats following
alpha-naphthylisothiocyanate (ANIT) administration. Toxicol Appl
Pharmacol. 119:108–114. 1993. View Article : Google Scholar
|
|
4
|
Roth RA and Dahm LJ: Neutrophil- and
glutathione-mediated hepatotoxicity of
alpha-naphthylisothiocyanate. Drug Metab Rev. 29:153–165. 1997.
View Article : Google Scholar
|
|
5
|
Yoshidome H, Miyazaki M, Shimizu H, Ito H,
Nakagawa K, Ambiru S, Nakajima N, Edwards MJ and Lentsch AB:
Obstructive jaundice impairs hepatic sinusoidal endothelial cell
function and renders liver susceptible to hepatic
ischemia/reperfusion. J Hepatol. 33:59–67. 2000. View Article : Google Scholar
|
|
6
|
Tekin R, Yolbas I, Dal T, Demirpençe Ö,
Kaya S, Bozkurt F, Deveci Ö, Çelen MK and Tekin A: Evaluation of
adults with acute viral hepatitis a and review of the literature.
Clin Ter. 164:537–541. 2013.
|
|
7
|
Flora KD and Benner KG: Liver disease in
cystic fibrosis. Clin Liver Dis. 2:51–61. 1998. View Article : Google Scholar
|
|
8
|
Eaton JE, Talwalkar JA, Lazaridis KN,
Gores GJ and Lindor KD: Pathogenesis of primary sclerosing
cholangitis and advances in diagnosis and management.
Gastroenterology. 145:521–536. 2013. View Article : Google Scholar
|
|
9
|
Hirschfield GM, Chapman RW, Karlsen TH,
Lammert F, Lazaridis KN and Mason AL: The genetics of complex
cholestatic disorders. Gastroenterology. 144:1357–1374. 2013.
View Article : Google Scholar :
|
|
10
|
Fickert P, Pollheimer MJ, Silbert D,
Moustafa T, Halilbasic E, Krones E, Durchschein F, Thüringer A,
Zollner G, Denk H and Trauner M: Differential effects of norUDCA
and UDCA in obstructive cholestasis in mice. J Hepatol.
58:1201–1208. 2013. View Article : Google Scholar :
|
|
11
|
Makishima M, Okamoto AY, Repa JJ, Tu H,
Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ and Shan B:
Identification of a nuclear receptor for bile acids. Science.
284:1362–1365. 1999. View Article : Google Scholar
|
|
12
|
Parks DJ, Blanchard SG, Bledsoe RK,
Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki
AM, Moore DD and Lehmann JM: Bile acids: Natural ligands for an
orphan nuclear receptor. Science. 284:1365–1368. 1999. View Article : Google Scholar
|
|
13
|
Wang H, Chen J, Hollister K, Sowers LC and
Forman BM: Endogenous bile acids are ligands for the nuclear
receptor FXR/BAR. Mol Cell. 3:543–553. 1999. View Article : Google Scholar
|
|
14
|
Huber RM, Murphy K, Miao B, Link JR,
Cunningham MR, Rupar MJ, Gunyuzlu PL, Haws TF, Kassam A, Powell F,
et al: Generation of multiple farnesoid-X-receptor isoforms through
the use of alternative promoters. Gene. 290:35–43. 2002. View Article : Google Scholar
|
|
15
|
Goodwin B, Jones SA, Price RR, Watson MA,
McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, et al:
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1
represses bile acid biosynthesis. Mol Cell. 6:517–526. 2000.
View Article : Google Scholar
|
|
16
|
Xie MH, Holcomb I, Deuel B, Dowd P, Huang
A, Vagts A, Foster J, Liang J, Brush J, Gu Q, et al: FGF-19, a
novel fibroblast growth factor with unique specificity for FGFR4.
Cytokine. 11:729–735. 1999. View Article : Google Scholar
|
|
17
|
Kong B, Wang L, Chiang JY, Zhang Y,
Klaassen CD and Guo GL: Mechanism of tissue-specific farnesoid X
receptor in suppressing the expression of genes in bile-acid
synthesis in mice. Hepatology. 56:1034–1043. 2012. View Article : Google Scholar :
|
|
18
|
Meng Q, Chen XL, Wang CY, Liu Q, Sun HJ,
Sun PY, Huo XK, Liu ZH, Yao JH and Liu KX: Alisol B 23-acetate
protects against ANIT-induced hepatotoxity and cholestasis, due to
FXR-mediated regulation of transporters and enzymes involved in
bile acid homeostasis. Toxicol Appl Pharmacol. 283:178–186. 2015.
View Article : Google Scholar
|
|
19
|
Chen H, Huang X, Min J, Li W, Zhang R,
Zhao W, Liu C, Yi L, Mi S, Wang N, et al: Geniposidic acid
protected against ANIT-induced hepatotoxity and acute intrahepatic
cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. J
Ethnopharmacol. 179:197–207. 2016. View Article : Google Scholar
|
|
20
|
Severgnini M, Sherman J, Sehgal A,
Jayaprakash NK, Aubin J, Wang G, Zhang L, Peng CG, Yucius K, Butler
J and Fitzgerald K: A rapid two-step method for isolation of
functional primary mouse hepatocytes: Cell characterization and
asialoglycoprotein receptor based assay development.
Cytotechnology. 64:187–195. 2012. View Article : Google Scholar
|
|
21
|
Li T and Chiang JY: Bile acid signaling in
metabolic disease and drug therapy. Pharmacol Rev. 66:948–983.
2014. View Article : Google Scholar :
|
|
22
|
Schuetz EG, Strom S, Yasuda K, Lecureur V,
Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ,
et al: Disrupted bile acid homeostasis reveals an unexpected
interaction among nuclear hormone receptors, transporters, and
cytochrome P450. J Biol Chem. 276:39411–39418. 2001. View Article : Google Scholar
|
|
23
|
Tanaka Y, Aleksunes LM, Cui YJ and
Klaassen CD: ANIT-induced intrahepatic cholestasis alters
hepatobiliary transporter expression via Nrf2-dependent and
independent signaling. Toxicol Sci. 108:247–257. 2009. View Article : Google Scholar :
|
|
24
|
Wang T, Zhou ZX, Sun LX, Li X, Xu ZM, Chen
M, Zhao GL, Jiang ZZ and Zhang LY: Resveratrol effectively
attenuates α-naphthyl-isothiocyanate-induced acute cholestasis and
liver injurythrough choleretic and anti-inflammatory mechanisms.
Acta Pharmacol Sin. 35:1527–1536. 2014. View Article : Google Scholar :
|
|
25
|
Ding L, Yang L, Wang Z and Huang W: Bile
acid nuclear receptor FXR and digestive system diseases. Acta Pharm
Sin B. 5:135–144. 2015. View Article : Google Scholar :
|
|
26
|
Matsubara T, Li F and Gonzalez FJ: FXR
signaling in the enterohepatic system. Mol Cell Endocrinol.
368:17–29. 2013. View Article : Google Scholar
|
|
27
|
Greve JW, Gouma DJ and Buurman WA: Bile
acids inhibit endotoxin-induced release of tumor necrosis factor by
monocytes: An in vitro study. Hepatology. 10:454–458. 1989.
View Article : Google Scholar
|
|
28
|
Gu X, Ke S, Liu D, Sheng T, Thomas PE,
Rabson AB, Gallo MA, Xie W and Tian Y: Role of NF-kappaB in
regulation of PXR-mediated gene expression: A mechanism for the
suppression of cytochrome P-450 3A4 by proinflammatory agents. J
Biol Chem. 281:17882–17889. 2006. View Article : Google Scholar
|
|
29
|
Wang YD, Chen WD, Wang M, Yu D, Forman BM
and Huang W: Farnesoid X receptor antagonizes nuclear factor kappaB
in hepatic inflammatory response. Hepatology. 48:1632–1643. 2008.
View Article : Google Scholar :
|
